Programme
Click Here to download programme.
Please note this is subject to change. Images are low resolution for optimum online browsing.
The conference theme is ‘Biotechnology and The Future of Neuro-Oncology’ reflecting the exciting advancements that are taking place at the interface between neuro-oncology, biology and technology, and providing new hope for patients with brain cancer.
Building on previous congresses the programme will address the opportunities and challenges that have emerged in the field of biotechnology in recent years. BNOS 2025 will provide you with the latest insights and best practices in this rapidly evolving field.
You will benefit from a rich and diverse programme that covers all aspects of neuro-oncology research and practice, from basic science to emerging technology, and all aspects of clinical practice. We have a host of international and national keynote speakers who are worldwide leaders in neuro-oncology. See list of our speakers below or visit out speakers page for more information.
2025 Outline Programme – download here
Keynote Speakers
Gabriele Bergers | University of Leuven | Belgium
Shawn Hervey-Jumper | University of California San Francisco | USA
Parashkev Nachev | University College London | UK
Mario Luca Suvà | Harvard University | USA
Frank Winkler | University of Heidelberg | Germany
Confirmed Faculty
Marta María Alonso Roldán | Clinca Universidad de Navarra | Pamplona, Spain
Catrin Austin | NICE | UK
Rebecca Campbell-Jones | University College London | UK
David Capsey | University College London | UK
Sarah Casey | University College London | UK
Seema Dadhania | Imperial Healthcare NHS Trust | UK
Jamie Dean | University College London | UK
Annick Desjardins | Duke Cancer Institute | USA
Danielle Fairweather | University College London | UK
Marta Ferri | University College London | UK
Laura Fitzpatrick | University College London | UK
Karin Gehring | Tilburg University | Netherlands
Ben Hall | University College London | UK
Abby Harper-Payne | Imperial Healthcare NHS Trust | UK
Ahmed Id Baih | University Hospitals Pitié Salpêtrière – Charles Foix | France
Karthica Indramohan | University College London | UK
Shelley Jones | Kings College Hospital NHS Foundation Trust | UK
Chris Jones | The Institute of Cancer Research | UK
Brieuc Lehmann | University College London | UK
Hani Marcus | National Hospital for Neurology and Neurosurgery | UK
Sara Melhuish | Barts Health NHS Trust | UK
Thomas Millner | University College London | UK
Samantha Mills | Walton Centre NHS Foundation Trust | UK
Florent Mouliere | Cancer Research UK Manchester Institute | UK
Jessica O’Brien | University College London | UK
Marco Palombo | Cardiff University | UK
Simona Parrinello | University College London | UK
Gita Ramdharry | University College London | UK
Shanika Samarasekera | University Hospitals Birmingham NHS Trust | UK
Charlotte Smith | The Christie NHS Foundation Trust | UK
Magdalena Sokolska | University College London | UK
Shivani Soni | Imperial Healthcare NHS Trust | UK
Lucy Stead | University of Leeds | UK
Aoife Stone-Ghariani | University College London | UK
Karin Straathof | University College London | UK
Clare Toner | University College London | UK
Martin van den Bent | Erasmus MC Cancer Center in Rotterdam | Netherlands
Rhona Watson | Oxford University Hospitals NHS Foundation Trust | UK
Matt Williams | Imperial Healthcare NHS Trust | UK
Company Symposiums
We’re delighted to host a selection of exhibitor showcases throughout the conference in collaboration with our platinum and gold sponsors. These will be hosted in the Shaw Theatre during the Main Sessions. Please do not miss out on the opportunity to hear about the latest news and innovations.
Platinum exhibitor
Wednesday 18th June 2025 14:30-15:00 – Novocure
Tumour Treating Fields in Glioblastoma – Shaping the Future of Therapy
- Stuart Smith | Clinical Associate Professor in the Faculty of Medicine & Health Sciences at Queens Medical Centre, Nottingham
- Ola Rominiyi | NIHR Clinical Lecturer at The University of Sheffield
- Gerben Borst | Honorary Consultant Clinical Oncologist at The Christie NHS Foundation Trust, Manchester
Gold exhibitors
Thursday 19th June 2025 09:45-10:00 – myTomorrows
Transforming neuro-oncology clinical trials with AI-driven solutions – Enhancing equitable access
- Susan Short | Professor of Clinical Oncology at University of Leeds
Friday 20th June 2025 09:30-09:45 – Brainlab
The role of navigated TMS in neurosurgery
- Ahmad Ali | The Walton Centre NHS Foundation Trust
CPD
We are pleased to confirm that our 2025 annual meeting will be eligible for delegate CPD.
This year, CPD will be managed by our event organiser Aesculap Academy, who are an accredited centre of the Royal College of Surgeons of England (RCS). Delegates attending the conference will be requested to complete a post event survey, following which CPD points will be awarded, and electronic certificates sent out according to delegate registration/attendance.
RCS has an agreement with the other medical royal colleges through the Academy of Medical Royal Colleges which gives eligibility to award CPD points.
The Royal College of Surgeons of England has awarded up to 17.5 CPD points for the BNOS Annual Meeting 2025.
CPD points have been allocated per day. Aesculap Academy request that you verify your own CPD points in accordance with sessions attended.
Wednesday 18th June – 6
Thursday 19th June – 7
Friday 20th June – 4.5